This area of research is exploring the role of antiviral treatment in protecting a polio-free role following eradication.
There are three situations anticipated for polio antiviral drug use:
In 2006, the Poliovirus Antivirals Initiative was established. Its immediate goal was to determine if candidate antiviral drugs were safe and able to prevent, reduce or stop poliovirus shedding in adults given the oral polio vaccine. Drug candidates under review include capsid inhibitors and protease inhibitors. Funding has been approved for a project to identify new antiviral compounds against polioviruses through industrial-scale mass screening of compounds and evaluation of candidate compounds in vitro and in mouse models.
The Global Polio Eradication Initiative © Copyright 2010